findmyKOL

Vinodh Jeevanantham, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI
RegionOklahoma City, OK · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2020Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Vinodh Jeevanantham is a Cardiology physician. OpenAlex indexes 75 publications with 1,882 citations (h-index 22).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
75publications

Distinct works indexed by OpenAlex.

1,882citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
17companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3400 S Douglas Blvd
Suite 200
Oklahoma City, OK 731501001

Telephone

405-737-7000

Provider last certified this registry record 26 Oct 2020.

View the NPPES registry record

Industry payments

17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.2%
    Beta blocker21.1%
    Metoprolol Succinate47%Carvedilol28%Metoprolol Tartrate19%Sotalol2%Atenolol2%Propranolol Hcl1%Nebivolol Hcl1%
    Part D<11 patients
    Statin11%
    Atorvastatin Calcium74%Rosuvastatin Calcium11%Pravastatin Sodium10%Simvastatin5%
    Part D186 patients

    + 16 more classes in this area

  • Blood & clotting

    17.3%
    P2Y12 inhibitor8.3%
    Clopidogrel91%Brilinta9%
    Part D175 patients
    Factor Xa inhibitor7.7%
    Eliquis92%Xarelto8%
    Part D<11 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    3.5%
    Potassium supplement2.6%
    Potassium Chloride100%
    Part D80 patients
    SGLT2 inhibitor0.6%
    Jardiance55%Farxiga45%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)81.4% facility · 18.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”